Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Brunner HI, Ruperto N, Ramanan AV, Horneff G, Minden K, Calvo Penades I, Alexeeva E, Cleary G, Stern SM, Kone-Paut I, Maldonado Velázquez MDR, Rabinovich CE, Remesal A, Silva CA, Nikishina I, Zucchetto M, Brockwell L, Gordon O, Nagel S, De Benedetti F; PRINTO and PRCSG Investigators. Brunner HI, et al. Among authors: zucchetto m. Rheumatology (Oxford). 2024 Sep 1;63(9):2535-2546. doi: 10.1093/rheumatology/keae180. Rheumatology (Oxford). 2024. PMID: 38552315 Free PMC article. Clinical Trial.
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort.
Ghuman A, Khanna D, Lin CJF, Furst DE, Raghu G, Martinez FJ, Zucchetto M, Huang S, Jennings A, Nihtyanova SI, Denton CP. Ghuman A, et al. Among authors: zucchetto m. Rheumatology (Oxford). 2024 Feb 1;63(2):472-481. doi: 10.1093/rheumatology/kead234. Rheumatology (Oxford). 2024. PMID: 37228011 Free PMC article. Clinical Trial.
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
Khanna D, Lin CJF, Furst DE, Wagner B, Zucchetto M, Raghu G, Martinez FJ, Goldin J, Siegel J, Denton CP. Khanna D, et al. Among authors: zucchetto m. Am J Respir Crit Care Med. 2022 Mar 15;205(6):674-684. doi: 10.1164/rccm.202103-0714OC. Am J Respir Crit Care Med. 2022. PMID: 34851799 Clinical Trial.
First-contact incidence of psychosis in north-eastern Italy: influence of age, gender, immigration and socioeconomic deprivation.
Lasalvia A, Bonetto C, Tosato S, Zanatta G, Cristofalo D, Salazzari D, Lazzarotto L, Bertani M, Bissoli S, De Santi K, Cremonese C, De Rossi M, Gardellin F, Ramon L, Zucchetto M, Amaddeo F, Tansella M, Ruggeri M; PICOS-Veneto Group. Lasalvia A, et al. Among authors: zucchetto m. Br J Psychiatry. 2014 Aug;205(2):127-34. doi: 10.1192/bjp.bp.113.134445. Epub 2014 Apr 10. Br J Psychiatry. 2014. PMID: 24723631
32 results